• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利白塞病患者血栓形成因素的研究。

A study on thrombophilic factors in Italian Behcet's patients.

机构信息

Dipartimento di Medicina Clinica Sperimentale, Policlinico G.B. Rossi, Piazzale Scuro, 37134 Verona, Italy.

出版信息

Joint Bone Spine. 2010 Jul;77(4):330-4. doi: 10.1016/j.jbspin.2010.02.022. Epub 2010 May 8.

DOI:10.1016/j.jbspin.2010.02.022
PMID:20452800
Abstract

BACKGROUND

Behcet's disease (BD) may complicate with arterial and venous thrombosis. The purpose of this work is to evaluate in an Italian group of BD patients with thrombotic events a large panel of inherited and acquired thrombophilic factors.

METHODS

Thirty BD patients, of which nine with previously arterial or venous thrombosis and 21 without, underwent the following investigations: plasma antithrombin activity, protein C activity, free protein S level, sensitivity to APC, total plasma homocysteine concentration, serum folate level, determination of anti-phospholipid antibodies, serum Lp(a) levels, tests for gene polymorphisms of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase genes. Tests for the gene polymorphisms were also performed in a group of healthy control subjects.

RESULTS

All the six patients with arterial or deep venous thrombosis showed thrombophilic conditions such as protein C or protein S deficiency (one case each), hyperhomocysteinemia (two cases), positivity of anti-phospholipid antibodies associated with APC resistance or hyperhomocysteinemia (one case each). Among three subjects with superficial thrombophlebitis only one showed a mild hyperhomocysteinemia. No differences were found between BD patients and control subjects concerning polymorphisms of the genes considered. Among BD patients the Factor V H1299R mutation showed a weak association with venous thrombosis (P=0.048).

CONCLUSION

In BD patients different concomitant significant thrombophilic risk factors may contribute to the development of thrombotic events. Patients affected by vasculo-Behcet should be evaluated for the presence of coexisting major thrombophilic conditions.

摘要

背景

白塞病(BD)可能并发动脉和静脉血栓形成。本研究的目的是评估意大利一组BD 患者伴血栓形成事件时存在的多种遗传性和获得性血栓形成倾向因素。

方法

30 例 BD 患者,其中 9 例之前有动脉或静脉血栓形成,21 例无血栓形成,进行了以下检查:血浆抗凝血酶活性、蛋白 C 活性、游离蛋白 S 水平、对 APC 的敏感性、总血浆同型半胱氨酸浓度、血清叶酸水平、抗磷脂抗体测定、血清 Lp(a)水平、凝血因子 V Leiden、凝血酶原和亚甲基四氢叶酸还原酶基因的多态性检测。还在一组健康对照受试者中进行了基因多态性检测。

结果

6 例有动脉或深静脉血栓形成的患者均存在血栓形成倾向,如蛋白 C 或蛋白 S 缺乏(各 1 例)、高同型半胱氨酸血症(2 例)、抗磷脂抗体阳性伴 APC 抵抗或高同型半胱氨酸血症(各 1 例)。3 例浅表血栓性静脉炎患者中仅 1 例存在轻度高同型半胱氨酸血症。BD 患者与对照组之间考虑的基因多态性无差异。BD 患者中凝血因子 V H1299R 突变与静脉血栓形成有弱相关性(P=0.048)。

结论

在 BD 患者中,不同的同时存在的显著血栓形成倾向因素可能导致血栓形成事件的发生。患有血管白塞病的患者应评估是否存在并存的主要血栓形成倾向。

相似文献

1
A study on thrombophilic factors in Italian Behcet's patients.意大利白塞病患者血栓形成因素的研究。
Joint Bone Spine. 2010 Jul;77(4):330-4. doi: 10.1016/j.jbspin.2010.02.022. Epub 2010 May 8.
2
Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.西班牙东部白塞病患者的血栓形成风险因素和同型半胱氨酸水平及其与血栓形成事件的关联
Thromb Haemost. 2006 Apr;95(4):618-24.
3
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.亚甲基四氢叶酸还原酶 C677T 和 A1298C 多态性与白塞病患者同型半胱氨酸浓度的变化。
Gene. 2013 Sep 15;527(1):306-10. doi: 10.1016/j.gene.2013.06.041. Epub 2013 Jul 1.
4
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.因子 V 莱顿、凝血酶原和亚甲基四氢叶酸还原酶等位基因变异与白塞病血栓形成或眼部受累的关联:系统评价和荟萃分析。
Autoimmun Rev. 2013 Mar;12(5):607-16. doi: 10.1016/j.autrev.2012.11.001. Epub 2012 Nov 30.
5
Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin.血管贝赫切特病与血栓形成相关基因的突变:亚甲基四氢叶酸还原酶、凝血因子V和凝血酶原。
Genet Test Mol Biomarkers. 2012 Jan;16(1):30-5. doi: 10.1089/gtmb.2011.0096. Epub 2011 Aug 23.
6
Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.因子V基因G1691A、亚甲基四氢叶酸还原酶基因C677T和凝血酶原基因G20210A突变对白塞病深静脉血栓形成的影响。
J Rheumatol. 2000 Dec;27(12):2849-54.
7
Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease.白塞病患者的凝血因子V基因(1691A和4070G)及凝血酶原基因20210A突变
Pathophysiol Haemost Thromb. 2003 May-Jun;33(3):157-63. doi: 10.1159/000077824.
8
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.意大利白塞病合并深静脉血栓形成患者的凝血因子V莱顿突变和凝血酶原基因G20210A突变
Arthritis Rheum. 2004 Apr 15;51(2):177-83. doi: 10.1002/art.20237.
9
Hyperhomocysteinaemia in Behçet's disease.白塞病中的高同型半胱氨酸血症。
Rheumatology (Oxford). 2001 Jun;40(6):687-90. doi: 10.1093/rheumatology/40.6.687.
10
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.白塞病中的血管受累:与血栓形成倾向因素、凝血激活及血栓调节蛋白的关系。
Am J Med. 2002 Jan;112(1):37-43. doi: 10.1016/s0002-9343(01)01048-8.

引用本文的文献

1
Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion.白塞病相关性与特发性视网膜分支静脉阻塞的临床特征研究。
Indian J Ophthalmol. 2020 Sep;68(9):1876-1880. doi: 10.4103/ijo.IJO_217_20.
2
Recurrent Myocardial Infarction Despite Normal C-reactive Protein in a Patient with Behcet's Disease and Compound Heterozygous Methylenetetrahydrofolate Reductase (MTHFR) Mutations (C677T and A1298C).白塞病合并亚甲基四氢叶酸还原酶(MTHFR)复合杂合突变(C677T和A1298C)患者尽管C反应蛋白正常仍发生复发性心肌梗死
Cureus. 2019 Aug 8;11(8):e5344. doi: 10.7759/cureus.5344.
3
Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment.
在阿尔及利亚患者不同临床表现的 Behçet 病期间进行自身免疫谱评估:皮质类固醇治疗的影响。
Inflammopharmacology. 2019 Dec;27(6):1113-1122. doi: 10.1007/s10787-019-00567-8. Epub 2019 Feb 5.
4
Left ventricular intracardiac thrombus in a patient with Behçet disease successfully treated with immunosuppressive agents without anticoagulation: a case report and review of the literature.白塞病患者左心室内血栓经免疫抑制剂成功治疗且未进行抗凝:一例病例报告及文献复习
Rheumatol Int. 2015 Nov;35(11):1931-5. doi: 10.1007/s00296-015-3306-1. Epub 2015 Jun 9.
5
Thrombosis in vasculitis: from pathogenesis to treatment.血管炎中的血栓形成:从发病机制到治疗
Thromb J. 2015 Apr 16;13:15. doi: 10.1186/s12959-015-0047-z. eCollection 2015.
6
Activated protein C resistance in Behcet's disease.贝赫切特病中的活化蛋白 C 抵抗。
Thromb J. 2013 Sep 2;11(1):17. doi: 10.1186/1477-9560-11-17.
7
Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease.亚甲基四氢叶酸还原酶基因C677T突变与白塞病中秋水仙碱无反应性之间的关联。
Mol Vis. 2012;18:1696-700. Epub 2012 Jun 22.
8
Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.白塞病:心血管受累的新概念及治疗的未来方向
ISRN Pharmacol. 2012;2012:760484. doi: 10.5402/2012/760484. Epub 2012 Mar 8.